Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17945749 | 0.95 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945972 | 0.94 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL16613193 | 0.87 | ALDH1A1 (0.51) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945914 | 0.85 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17946062 | 0.83 | MEN1 (0.44) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945311 | 0.81 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945261 | 0.81 | KMT2A (0.48) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945249 | 0.80 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL17945698 | 0.78 | MEN1 (0.46) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL23132061 | 0.77 | KMT2A (0.48) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160218301-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-20160218301-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160218301-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CRY1, CRY2, NR2E3 | ALDH1A1 252/4885HPGD 1235/4885KDM4E 1127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.